X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Merck Ltd with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs MYLAN (US) - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 MERCK LTD   MYLAN
EQUITY SHARE DATA
    MERCK LTD
Dec-17
MYLAN
Dec-14
MERCK LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,3584,285-   
Low Rs9333,019-   
Sales per share (Unadj.) Rs665.01,466.8-  
Earnings per share (Unadj.) Rs56.6176.7-  
Cash flow per share (Unadj.) Rs72.5284.4-  
Dividends per share (Unadj.) Rs15.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs441.7729.1-  
Shares outstanding (eoy) m16.60378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x1.72.5 69.2%   
Avg P/E ratio x20.220.7 97.9%  
P/CF ratio (eoy) x15.812.8 123.1%  
Price / Book Value ratio x2.65.0 51.8%  
Dividend payout %26.50-   
Avg Mkt Cap Rs m19,0111,381,812 1.4%   
No. of employees `0001.525.0 6.2%   
Total wages/salary Rs m1,6960-   
Avg. sales/employee Rs Th7,150.022,199.6 32.2%   
Avg. wages/employee Rs Th1,098.70-   
Avg. net profit/employee Rs Th608.22,674.3 22.7%   
INCOME DATA
Net Sales Rs m11,040554,991 2.0%  
Other income Rs m240-3,235 -7.4%   
Total revenues Rs m11,279551,756 2.0%   
Gross profit Rs m1,376138,029 1.0%  
Depreciation Rs m26440,762 0.6%   
Interest Rs m023,939 0.0%   
Profit before tax Rs m1,35270,093 1.9%   
Minority Interest Rs m0-288 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m1700-   
Tax Rs m5832,947 19.8%   
Profit after tax Rs m93966,858 1.4%  
Gross profit margin %12.524.9 50.1%  
Effective tax rate %43.14.2 1,025.2%   
Net profit margin %8.512.0 70.6%  
BALANCE SHEET DATA
Current assets Rs m7,523487,910 1.5%   
Current liabilities Rs m2,253381,448 0.6%   
Net working cap to sales %47.719.2 248.9%  
Current ratio x3.31.3 261.1%  
Inventory Days Days5278 66.8%  
Debtors Days Days41107 37.8%  
Net fixed assets Rs m1,240128,396 1.0%   
Share capital Rs m16619,626 0.8%   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,333275,885 2.7%   
Long term debt Rs m0412,145 0.0%   
Total assets Rs m9,9121,111,240 0.9%  
Interest coverage xNM3.9-  
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x1.10.5 223.0%   
Return on assets %9.58.2 116.0%  
Return on equity %12.824.2 52.8%  
Return on capital %20.813.6 152.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m53772,954 0.7%  
From Investments Rs m-476-57,534 0.8%  
From Financial Activity Rs m-220-19,223 1.1%  
Net Cashflow Rs m-160-3,803 4.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare MERCK LTD With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare MERCK LTD With: STERLING BIOTECH  NOVARTIS  SANOFI INDIA  STRIDES PHARMA SCIENCE  UNICHEM LAB  



Today's Market

Sensex Ends 317 Points Higher; Realty and FMCG Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours of trade and ended the day on a strong note. Gains were largely seen in the realty sector and FMCG sector.

Related Views On News

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (1QFY19); Net Profit Up 63.1% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, MERCK LTD has posted a net profit of Rs 328 m (up 63.1% YoY). Sales on the other hand came in at Rs 2 bn (down 17.1% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Nov 19, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - CADILA HEALTHCARE COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS